El Hospital Universitario Puerta de Hierro de Majadahonda es un centro hospitalario de titularidad pública, situado en la calle Manuel de Falla 1, de Majadahonda.

During the past decade, Hospital Universitario Puerta de Hierro Majadahonda conducted 424 clinical trials. In the 10-year time frame, 424 clinical trials started and 140 clinical trials were completed, i.e. on average, 33% percent of trials that started reached the finish line to date. In the past 5 years, 152 clinical trials started and 78 clinical trials were completed. i.e. 51.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Puerta de Hierro Majadahonda" #1 sponsor was "Pfizer" with 24 trials, followed by "Gilead Sciences" with 21 trials sponsored, "Hoffmann-La Roche" with 20 trials sponsored, "Puerta de Hierro University Hospital" with 20 trials sponsored and "PETHEMA Foundation" with 20 trials sponsored. Other sponsors include 518 different institutions and companies that sponsored additional 279 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Puerta de Hierro Majadahonda" #1 collaborator was "Instituto de Salud Carlos III" with 10 trials as a collaborator, "Bristol-Myers Squibb" with 8 trials as a collaborator, "Merck Sharp & Dohme LLC" with 8 trials as a collaborator, "AstraZeneca" with 7 trials as a collaborator and "Abbott Medical Devices" with 6 trials as a collaborator. Other collaborators include 302 different institutions and companies that were collaborators in the rest 229 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Puerta de Hierro Majadahonda" are "Breast Cancer" (15 trials), "Non-small Cell Lung Cancer" (15 trials), "Atrial Fibrillation" (14 trials), "Carcinoma, Non-Small-Cell Lung" (10 trials) and "Coronary Artery Disease" (10 trials). Many other conditions were trialed in "Hospital Universitario Puerta de Hierro Majadahonda" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Puerta de Hierro Majadahonda" are "Drug" (436 trials), "Other" (67 trials), "Device" (57 trials), "Biological" (41 trials) and "Procedure" (27 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (122 trials), "Carboplatin" (23 trials), "Paclitaxel" (15 trials), "Cisplatin" (13 trials) and "Docetaxel" (12 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Puerta de Hierro Majadahonda" are 580 trials for "All" genders, 29 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are 227 active trials in "Hospital Universitario Puerta de Hierro Majadahonda". 3 are not yet recruiting, 127 are recruiting, 94 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 277 completed trials in Hospital Universitario Puerta de Hierro Majadahonda, 2 suspended trials, and 68 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Puerta de Hierro Majadahonda, 27 "Phase 1" clinical trials were conducted, 176 "Phase 2" clinical trials and 226 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 54 trials, and there were also 45 trials that are defined as “Not Applicable".

Hospital Universitario Puerta de Hierro Majadahonda has several departments that took part in Clinical trials: "Hospital Universitario Puerta de Hierro; Servicio de Hematologia" - 4 trials, "Hospital Universitario Puerta de Hierro; Servicio de Neurologia" - 3 trials, "Hospital Universitario Puerta de Hierro Majadahonda; Servicio de Neumología" - 3 trials